Wyeth Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WYETH PHARMS, and what generic alternatives to WYETH PHARMS drugs are available?
WYETH PHARMS has thirty-one approved drugs.
There are six US patents protecting WYETH PHARMS drugs.
There are fifty-six patent family members on WYETH PHARMS drugs in thirty countries and thirty-six supplementary protection certificates in thirteen countries.
Summary for Wyeth Pharms
| International Patents: | 56 |
| US Patents: | 6 |
| Tradenames: | 29 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for Wyeth Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms | PROTONIX | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020987-002 | Jun 12, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Pharms | TRIPHASIL-21 | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 019192-001 | Nov 1, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Wyeth Pharms Inc | ORUVAIL | ketoprofen | CAPSULE, EXTENDED RELEASE;ORAL | 019816-002 | Feb 8, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Wyeth Pharms Inc | QUINIDEX | quinidine sulfate | TABLET, EXTENDED RELEASE;ORAL | 012796-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-003 | Jan 20, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Wyeth Pharms | INDERAL | propranolol hydrochloride | TABLET;ORAL | 016418-009 | Oct 18, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Wyeth Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | RE36247 | ⤷ Try a Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-001 | Nov 17, 1995 | RE36247 | ⤷ Try a Trial |
| Wyeth Pharms | OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 016672-001 | Approved Prior to Jan 1, 1982 | 3,959,322 | ⤷ Try a Trial |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-004 | Dec 28, 1993 | 4,535,186*PED | ⤷ Try a Trial |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-006 | Dec 28, 1993 | 6,274,171 | ⤷ Try a Trial |
| Wyeth Pharms | OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 016806-001 | Approved Prior to Jan 1, 1982 | 3,666,858 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for WYETH PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 0.09 mg/0.02 mg | ➤ Subscribe | 2007-10-05 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg and 40 mg | ➤ Subscribe | 2004-02-02 |
| ➤ Subscribe | Tablets | 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg | ➤ Subscribe | 2005-11-03 |
| ➤ Subscribe | For Injection | 12 g/1.5 g per vial (pharmacy bulk) | ➤ Subscribe | 2011-12-06 |
International Patents for Wyeth Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Ecuador | SP066538 | ⤷ Try a Trial |
| Russian Federation | 2006114690 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2005100316 | ⤷ Try a Trial |
| Panama | 8629101 | ⤷ Try a Trial |
| South Korea | 20060118452 | ⤷ Try a Trial |
| Japan | 2007507553 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wyeth Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0802183 | 09C0048 | France | ⤷ Try a Trial | PRODUCT NAME: BAZEDOXIFENE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/09/511/001 DU 20090417; REGISTRATION NO/DATE AT EEC: EU/1/09/511/001-004 DU 20090417 |
| 1539166 | 2013C/064 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DEXTROMETHORPHANE OU UN SEL, PRCURSEUR DE DERIVE PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE BROMHYDRURE DE DEXTROMETORPHANE ET EN PARTICULIER LE BROMHYDRURE DE DEXTROMETROPHANE MONHYDRATE ET QUINIDINE OU UN SEL,....; AUTHORISATION NUMBER AND DATE: EU/1/13/833 20130626 |
| 1539166 | 13C0062 | France | ⤷ Try a Trial | PRODUCT NAME: (A) DEXTROMETHORPHAN OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE BROMHYDRATE DE DEXTROMETHORPHAN ET EN PARTICULIER LE MONOHYDRATE DE BROMHYDRATE DE DEXTROMETHORPHAN (B) QUINIDINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, PAR EXEMPLE LE SULFATE DE QUINIDINE EN PARTICULIER LE DIHYDRATE DE SULFATE DE QUINIDINE; REGISTRATION NO/DATE: EU/1/13/833/001-003 20130626 |
| 0502314 | C300095 | Netherlands | ⤷ Try a Trial | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
| 0771217 | CA 2006 00038 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
| 1453521 | CA 2016 00016 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
